← Back to Find funding

National Institutes of Health · Department of Health and Human Services

Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)

Open

In short: National Institutes of Health expects to make 6 awards.

Key facts

Deadline
Due Feb 11, 2027 · 81 days left
Award size
Not stated: see the official notice
Total available
$19M · about 6 awards
Match ?
Not required · Work out your budget and match
Who can apply
Set by the official notice: see Who can apply below
Where
Anywhere in the U.S., including Tennessee

What changed

  • Status changed from opening soon to open (seen Oct 15, 2026)
  • Deadline moved from Jul 14, 2026 to Feb 11, 2027 (seen Oct 15, 2026)
  • Deadline confirmed by the funder (seen Oct 15, 2026)
  • Opening date moved to Oct 15, 2026 (seen Oct 15, 2026)

Before you apply: federal grants require an active SAM.gov registration (Unique Entity ID) and a Grants.gov account. Registration is free but can take weeks, so start now, not when the deadline is close. Get-ready checklist

How this fits you

  • Available in Tennessee (nationwide program)
  • No match required
  • Past Tennessee awards on file: 101

Tell us who you are to see whether you're eligible.

About this grant

This is a Notice of Funding Opportunity (NOFO) for a Limited Competition that will invite application(s) from eligible organization(s) to apply. Please see Section III. Eligibility for additional information. In accordance with NIH standard peer-review processes, the application(s) will be peer-reviewed, and only meritorious application(s) will be considered for funding. Through this limited competition Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits applications to support continuation of two biospecimen banking resources. The National Clinical Trials Network (NCTN) Biospecimen Banks (NCTN Biobanks) support the NCI-funded NCTN and the Community Oncology Research Program (NCORP), and The Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) supports the Experimental Therapeutics Clinical Trials Network (ETCTN) and other NCI-supported early phase and experimental clinical trials. The objective is to maintain these national resources for the collection, processing, storage, and distribution of high-quality, clinically annotated human biospecimens. The goal of these resources is to ensure the availability of biospecimens from participants in NCI-funded clinical trials focused on treatment, prevention, and cancer control studies to enable translational cancer research. The NCTN Biobanks support biomarker development and validation, secondary correlative studies, and broader scientific discovery using biospecimens collected through harmonized protocols and linked to clinical outcome data from large multi-site clinical trials. The EET Biobank supports biospecimen banking for ETCTN and other early-phase and experimental therapeutic clinical trials involving investigational agents. Biospecimens collected through these studies support biomarker assay development, pharmacokinetic and pharmacodynamic analyses, investigation of drug response and resistance mechanisms, patient stratification, and translational research supporting development of novel cancer therapies. In accordance with NIH standard peer-review processes, the application(s) will be peer-reviewed, and only meritorious application(s) will be considered for funding.

Who can apply, from the official notice

Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility. · Eligibility is limited to an institution/entity that is the recipient of an existing NCTN biobank of human biospecimens from NCI clinical trials funded under RFA-CA-20-002 or an existing EET Biobank of human specimens under RFA-CA-20-003. · Foreign Organizations/International Collaborations: Non-domestic (non-U. · S.) Entities (Foreign Organizations) are not eligible to apply. · Non-domestic (non-U. · S.) components of U. · S. Organizations are not eligible to apply. · Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

View on Grants.gov Add deadline to my calendar

Ask a partner for a letter

Your schedule, working back from the deadline

  1. Nov22
    Check that your SAM.gov registration is active (or start it now)
    Grants.gov: allow up to 10 business days for SAM registration, weeks or months if information isn't verified. It must be renewed every year. Grants.gov
  2. Jan21
    Ask partners for letters of support or commitment
    Suggested: partners need about three weeks to write and sign letters.
  3. Feb4
    Finish a complete draft for a final review
    Suggested: leave about a week for someone else to read the draft.
  4. Feb9
    Submit
    Grants.gov: submit at least 24–48 hours before the deadline: uploads fail, systems slow down, errors need fixing. Grants.gov blog
  5. Feb11
    Deadline
    From the funder.

Save this grant to put these dates in My grants and your private calendar.

Who in Tennessee has won this program

34 awards to Tennessee groups in 2 counties since 2010. Largest shown:

Past Tennessee winners
Past winnerWhereAmountFiscal year
Vanderbilt University Medical CenterNashville, Davidson County$12.8M2010
Vanderbilt University Medical CenterNashville, Davidson County$12.6M2014
Vanderbilt University Medical CenterNashville, Davidson County$12.2M2018
Vanderbilt University Medical CenterNashville, Davidson County$7.3M spent that year2025
St Jude Children's Research Hospital IncMemphis, Shelby County$4.4M2016
Vanderbilt University Medical CenterNashville, Davidson County$3.4M2021
St Jude Children's Research Hospital IncMemphis, Shelby County$3.4M2019
Vanderbilt University Medical CenterNashville, Davidson County$3.3M2021
St Jude Children's Research Hospital IncMemphis, Shelby County$3M2021
Vanderbilt UniversityNashville, Davidson County$3M2025
Vanderbilt University Medical CenterNashville, Davidson County$3M2019
Vanderbilt UniversityNashville, Davidson County$2.7M2018

Source: USAspending.gov; Federal Audit Clearinghouse. Past awards show who this program funds. They don't guarantee future awards.

Tennessee groups that got this money through a state agency or another organization

This federal money also reaches local groups as pass-through grants. 67 pass-through grants on file. Largest shown:

Tennessee pass-through grant winners
Past winnerWhereThroughAmountFiscal year
Vanderbilt UniversityNashville, Davidson CountyVanderbilt University Medical Center$2.5M2023
Vanderbilt University Medical CenterNashville, Davidson CountyRegents of the University of Michigan$974K2023
University of TennesseeMemphis, Shelby CountyUniversity of Alabama at Birmingham$718K2025
St Jude Children's Research Hospital IncMemphis, Shelby CountyThe Children's Hospital of Philadelphia$711K2025
St. Jude Children's Research Hospital, Inc.Memphis, Shelby CountyUniversity of Florida$618K spent that year2025
Vanderbilt University Medical CenterNashville, Davidson CountyThe University of Texas Southwestern Medical Center$523K2026
Vanderbilt UniversityNashvilleVanderbilt University Medical Center$520K spent that year2025
St Jude Children's Research Hospital IncMemphis, Shelby CountyUniversity of Florida$480K2026
St Jude Children's Research Hospital IncMemphis, Shelby CountyUniversity of Florida$472K2026
Vanderbilt UniversityNashvilleVumc$431K spent that year2024
Vanderbilt University Medical CenterNashville, Davidson CountyIcahn School of Medicine at Mount Sinai$330K2024
Vanderbilt UniversityNashville, Davidson CountyCase Western Reserve University$328K2024

Source: USAspending.gov pass-through reports (the first recipient reports each one of $30,000 or more).

Similar grants open or opening soon

From other funders, about the same kind of work.

More from National Institutes of Health

About the federal program

Cancer Detection and Diagnosis Research
Program number 93.394 (the federal Assistance Listing number) · U.S. Department of Health and Human Services, National Institutes of Health · Cooperative agreement (a grant with close agency involvement), project grant

How applications are judged

The major elements in evaluating proposals include assessments of: (1) The scientific merit and general significance of the proposed study and its objectives; 2) the technical adequacy of the experimental design and approach; (3) the competency of the proposed investigator or group to successfully pursue the project; (4) the adequacy of the available and proposed facilities and resources; (5) the necessity of the budget components requested in relation to the proposed project; and (6) the relevance and importance to announced program objectives. The following criteria will be used in considering the scientific and technical merit of SBIR/STTR Phase I grant applications: (1) The soundness and technical merit of the proposed approach; (2) the qualifications of the proposed principal investigator, supporting staff, and consultants; (3) the technological innovation of the proposed research; (4) the potential of the proposed research for commercial application; (5) the appropriateness of the budget requested; (6) the adequacy and suitability of the facilities and research environment; and (7) where applicable, the adequacy of assurances detailing the proposed means for (a) safeguarding human or animal subjects, and/or (b) protecting against or minimizing any adverse effect on the environment. Phase II grant applications will be reviewed based upon the following criteria: (1) The degree to which the Phase I objectives were met and feasibility demonstrated; (2) the scientific...

Match

None required (federal program listing).

This program on SAM.gov

Something wrong on this page? Tell us
What's wrong?

Source: Federal grants from Grants.gov · the official federal record. Last checked by GrantMe Nov 22, 2026.

Reference numbers: official notice number RFA-CA-28-004 · program number 93.394